ADC Therapeutics SA ADCT 深 沪
已收盘 08-01 16:00:00 美东时间
2.69
-0.080
-2.89%
华盛通- 最 高2.74
- 今 开2.72
- 成交量 66.90万股
- 最 低 2.59
- 昨 收 2.77
- 总市值 2.67亿
- 52周最高 3.97
- 市盈率 静 --
- 换手率 0.67%
- 52周最低 1.05
- 委 比 -83.79%
- 总股本 9922.97万
- 历史最高 56.59
- 量 比 0.92
- 振 幅 5.42%
- 历史最低 0.3599
- 每 手 1
- 风险率 0.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
LAUSANNE, Switzerland, Aug. 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today anno...
08-02 04:05
Aduro Clean Technologies Announces Grant of Stock Options and RSUs
Aduro Clean Technologies Inc. granted 743,500 stock options and 100,000 restricted share units (RSUs) to its directors, officers, employees, and consultants. The stock options have an exercise price of $13.50 per share and are exercisable over five years, vesting monthly over two years. The RSUs vest in three tranches over a year. All securities are subject to a four-month hold period. The granting of these options and RSUs aims to attract and re...
07-03 11:00
ADC Therapeutics files to sell 27.73M common shares by selling shareholders
ADC Therapeutics (NYSE:ADCT) filed a prospectus to sale 27.73 million shares of common stock. The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder. Thi...
07-01 05:36
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 26, 2025 /PRNewswire/ -- USA News Group News Commentary – With analysts forecasting the global ...
06-26 23:44
美股大行评级 | 潜在涨幅378.93%！aTyr Pharma获富国银行升目标价至25美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1143101010774646784.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 富国银行：维持aTyr Pharma(ATYR)"超配"评级，目标价从17美元升至25美元</p> <p>• 摩根大通：维持Array Technologies(ARRY)"超配"评级，目标价从12美元升至13美元</p>
06-21 08:35
RBC Capital Maintains Outperform on ADC Therapeutics, Lowers Price Target to $5
RBC Capital analyst Leonid Timashev maintains ADC Therapeutics (NYSE:ADCT) with a Outperform and lowers the price target from $8 to $5.
06-20 21:55
美股大行评级 | 潜在涨幅290.69%！乌龙制药获丰业银行升目标价至47美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1140565699993591809.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 丰业银行：维持乌龙制药(URGN)"跑赢大市"评级，目标价从23美元升至47美元</p> <p>• Guggenheim：维持ADC Therapeutics(ADCT)"买入"评级，目标价从7美元升至10美元</p>
06-16 08:40
ADC reports data from lymphoma trial, streamlines operations
ADC Therapeutics (NYSE:ADCT), on Thursday, reported results from an early stage trial testing its antibody drug conjugate, Zynlonta, in combination with the bispecific antibody glofitamab to treat rel...
06-12 22:59
ADC Therapeutics Announces $100M Private Placement
ADC Therapeutics ( ($ADCT) ) has issued an announcement. On June 11, 2025, ADC ...
06-12 21:27
ADC Therapeutics announces $100M private financing
ADC Therapeutics (NYSE:ADCT) has entered into securities purchase agreements for the sale of its equity securities to certain institutional investors in a $100M private investment in public equity ("P...
06-12 19:32
